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ABSTRACT
The BioSample Database (http://www.ebi.ac.uk/
biosamples) is a new database at EBI that stores
information about biological samples used in mo-
lecular experiments, such as sequencing, gene ex-
pression or proteomics. The goals of the BioSample
Database include: (i) recording and linking of sample
information consistently within EBI databases such
as ENA, ArrayExpress and PRIDE; (ii) minimizing
data entry efforts for EBI database submitters by
enabling submitting sample descriptions once and
referencing them later in data submissions to assay
databases and (iii) supporting cross database
queries by sample characteristics. Each sample in
the database is assigned an accession number. The
database includes a growing set of reference
samples, such as cell lines, which are repeatedly
used in experiments and can be easily referenced
from any database by their accession numbers.
Accession numbers for the reference samples will
be exchanged with a similar database at NCBI. The
samples in the database can be queried by their at-
tributes, such as sample types, disease names or
sample providers. A simple tab-delimited format fa-
cilitates submissions of sample information to the
database, initially via email to biosamples@ebi.ac.uk
INTRODUCTION
Biological samples are now routinely assayed by various
high-throughput molecular technologies, such as
microarrays, new generation sequencing or mass spectros-
copy. Many data resources at the European
Bioinformatics Institute (EBI), such as the archive of func-
tional genomics data ArrayExpress (1), the European
Nucleotide Archive (ENA) (2), the Proteomics
Identiﬁcation Database PRIDE (3) and the European
Genome-phenome Archive (EGA) capture and represent
information about samples linked to the (molecular) data
they store. The same sample can be assayed by several
technologies; for instance, cancer samples are often
genotyped and proﬁled for DNA methylation and gene
expression. Samples may have a relationship between
them, for instance in cancer proﬁling the DNA of a
tumour sample is sometimes compared to the DNA
obtained from the tumour periphery or blood of the
same individual. To interpret data from such experiments,
it is important to know the essential sample attributes as
well as the relationship between different samples and
their sources. The attributes may specify the material
sampled, the site—organs, tissues and phenotypic infor-
mation, including disease states. We refer to all such
metadata as sample data (or sample information).
Most bioinformatics resources will record sample data
in the future, as molecular proﬁling has now moved from
creating reference datasets to proﬁling individuals and
speciﬁc conditions. Samples are often collected at one
site and then distributed to several remote sites, each for
a speciﬁc type of analysis. Some reference samples, such as
standard cell lines, are distributed commercially and
reused widely. Therefore it is becoming advantageous to
record sample information in a separate dedicated
database, which then can link out to the assay data
stored about a speciﬁc sample in the appropriate assay
databases.
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BioSamples Database (BioSD). The main goals of this
database are:
(1) to record and manage sample information consistent-
ly within the EBI and to link sample information to
assay data across multiple resources;
(2) to minimize data entry efforts for the user, in par-
ticular, to enable submissions of sample descriptions
only once and reference them later from other data-
bases and submissions;
(3) to support cross database sample queries by sample
description; and
(4) to build a continuously growing set of consistently
annotated samples that are repeatedly used in experi-
ments and can be easily referenced from any of the
databases within the EBI and externally. These are
termed reference layer samples.
To achieve these goals, we assign stable accession
numbers to samples in BioSD. Moreover, we have
agreed on a common accessioning system and sample
data exchange with the National Center for
Biotechnology Information (NCBI), which is developing
a similar database (http://www.ebi.ac.uk/biosamples/
documents/BioSampleDB_EBI_NCBI.pdf). All the refer-
ence layer samples will be exchanged, accessioned in a
coordinated way and made accessible from both NCBI
and EBI databases.
The BioSample Database is the culmination of previous
experience in recording and storing project and domain
speciﬁc sample data EBI in the last 10years.
ArrayExpress (4) was the ﬁrst database at EBI to deal
with complex sample annotation for high-throughput
gene expression data sets from 2002, other EBI molecular
assay databases have made similar efforts since. Jointly
with collaborators, we also developed the sample informa-
tion management system PASSIM (5) for pre-registering
and annotating samples collected for speciﬁc bio-medical
genomics projects where the sample annotation was
standardized, known in advance and tightly controlled.
This system is still used for sample annotation and
tracking in a number of projects including the
International Cancer Genomics Project on kidney cancer
CAGEKID. More recently, projects such as ISA
Infrastructure (6), have developed resources that can be
used to store data and sample annotations for multi-omics
projects in a study centric manner. The Sample
Availability System (SAIL) (7) was developed with the
purpose of integrating sample information across
BioBank collections.
A centralized sample repository such as BioSD must be
ﬂexible enough to capture any biological sample descrip-
tion for samples of a priori unknown types. Samples can
have complex links and may be grouped in many ways;
critically these links and groups may be unknown in
advance and may not be related to any particular
project or study at the point of submission. Existing
samples may be combined into new studies, and various
meta-analyses may be performed. The data resulting from
such studies need to be linked to samples when the data is
submitted at a later date. It must be made easy for biolo-
gists and project owners to pre-register samples, enter
available sample information and obtain accession
numbers. Information about samples may be incomplete
at the time of submission and expanded or corrected in-
crementally. Since the assay databases at the EBI already
hold large numbers of sample records, BioSD has to be
able to deal with this data and scale in the future to many
more.
The BioSD implementation supports these require-
ments. Samples can be submitted in a simple tabular
format, called SampleTab, and the database allows for
user-driven sample registration and submission as well
as incorporating data both from external reference collec-
tions (e.g. cell lines) and from a number of assay databases
at the EBI including ENA, ArrayExpress and PRIDE; it
already contains sample data from over a million samples.
BioSD can also act as the principal repository of sample
data for future assay databases which may prefer not to
store sample information locally, e.g. the database of
Genetic Variation DGVa at the EBI (8). Centralization
of sample information in this way allows consistency
checking of annotations, encourages use of common
terminologies, e.g. Experimental Factor Ontology (9)
and provides a single query portal for sample related
data. A simple query interface allows the user to query
all samples in BioSD by various properties or attributes
and to navigate to assay databases.
BioSD DATA MODEL AND IMPLEMENTATION
Sample data are represented as two types of objects:
samples and sample groups. Rather than develop
multiple different types of object to represent all possible
sample types (individual, blood, biopsy, cell line, mouse
strain, etc.), we model a generic sample and use attributes
to deﬁne types. A sample is an identiﬁable object to which
annotation such as species, disease information or cell
type is attached. Samples can be derived-from other
samples. For example, an individual can be represented
as a typed sample with sex, age and ethnicity information.
A blood sample obtained at a speciﬁc time from that in-
dividual would be represented as a separate sample linked
to the individual through the derived-from relationship.
Other types of relationships, such as pedigree relationships
between individuals, may also be recorded. Multiple
samples can be asserted to refer to aliquots of the same
physical material. These are modelled as multiple sample
objects in the database, and we establish equivalence rela-
tionships between them. This allows provenance informa-
tion to be recorded about the equivalence relationships, as
well as incremental addition of information to a particular
sample without creating information ownership conﬂicts.
In most cases samples are naturally grouped, for
instance, cell lines of a speciﬁc collection, e.g. the
National Institute of Aging, or the samples related to a
publication or project. Samples in the same group are typ-
ically annotated consistently, i.e. the same attributes are
provided for all (or at least most samples), and the same
terms are used to annotate all the samples in the group.
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different groups—samples representing human subjects
or bacterial cell cultures will have largely different attri-
butes, and we cannot automatically assume that attributes
of the same name in different sample groups has exactly
the same meaning or use the same terminology. Logically,
a sample may belong to more than one group.
Use of groups enables batch submissions. Assay data-
bases already commonly group samples, and queries can
return individual samples and related samples within a
group.
Data to populate the BioSD comes from three different
types of sources:
(1) Samples submitted directly to BioSD for referencing
in later data submissions to assay databases. For
example, commercial cell lines, or samples used in
large analysis projects such as ENCODE. We
propose a format called SampleTab to be used for
this route (see below).
(2) Sample data imported from assay databases (termed
assay samples). For existing assay databases, the
sample information is usually also retained in the
respective assay database, however new assay data-
bases at EBI may store sample information only in
the BioSD.
(3) Data exchange of reference samples submitted to
NCBI.
In many cases, there is a one-to-one relationship
between a submission and a sample group for samples
submitted to BioSD directly. A curated subset of samples
acquired this way (alongside with those exchanged with
the NCBI) constitutes the reference sample set. We are
also actively working with standard sample collections
to populate the database. Some samples acquired
through route 2 may also be included in the reference
set after curation. Note that route 1 supports the submis-
sion of samples belonging to coordinated multi-omics
studies—the samples are submitted to BioSD and then
referenced from the respective assay databases.
Sample groups are also used to provide information in
scenarios where it is not possible to release detailed infor-
mation about speciﬁc samples. For example, it may be
known that a group of human samples have age, sex
and birth date available, but for ethical reasons these
details cannot be provided. However, summary informa-
tion at the group level can be provided within ethical
guidelines, e.g. age is between 18 and 30years. Similarly,
for some toxicology data pooling of individual samples
has the consequence that only mean data per group of
samples is available.
Finally, using the group concept allows us for provision
of sample group context to support queries. For instance,
HeLa derived samples are used in assays and reference
collections. Provision of group level information such as
‘Coriell catalogue’ or ‘ArrayExpress experiment’ gives
context to query results when many hits appear.
The BioSample Database implementation was designed
to accommodate highly variable sample descriptions and
to be ﬂexible enough to support future changes without
large system modiﬁcations such as schema changes in
RDBMS. The core of BioSD is a custom graph-based
data engine that manages information as objects with
arbitrary sets of attributes attached, and which can be
linked by deﬁned relationships such as derived-from or
equivalent-to. The data engine includes a semantic descrip-
tion of loaded data such as types of objects, possible at-
tributes and relationships, and rules that allow objects to
have associations to attributes or relationships. Therefore,
the data model is ﬂexible, easy to extend and edit, enabling
us to focus on optimal data organization for our query
and data representation use cases, rather than conforming
to existing data constraints from multiple external
databases.
Using a semantically annotated graph for data descrip-
tion allows us to enrich information by inferring new re-
lationships between objects, e.g. sample equivalence,
pedigree relations and sample similarity. Data indexing
and search services are implemented that select and
process information from the object graph. The most im-
portant is a full text index that allows users to ﬁnd samples
and groups according to their annotations. BioSD
also supports tag-based search when user can select infor-
mation according to some pre-deﬁned tags used to
group samples by criteria such as data source or related
projects.
BioSD FILE FORMAT: SampleTab
We have developed a ﬁle format termed SampleTab to
represent information about BioSamples. This is aimed
primarily for use by biologists, is human readable,
suitable for data exchange, and was inspired by
spreadsheet-like tab-separated formats such as
MAGE-TAB (10) and ISA-TAB (11). Each SampleTab
ﬁle describes samples as a collection of attribute-value
pairs. In addition, each ﬁle contains information about
the provenance of both the sample material and the data
describing the samples. A full description of the
SampleTab ﬁle and examples for different sample types
are available (http://www.ebi.ac.uk/microarray-srv/biosd/
static/st.html), therefore only a brief summary is provided
here.
A SampleTab ﬁle is composed of two parts—a
Meta-Sample Information (MSI) section and a Sample
Characteristics Description (SCD) section. In a completed
SampleTab ﬁle, the start of these sections are indicated by
lines ‘[MSI]’ and ‘[SCD]’ respectively, but in a working
copy they may be stored as separate spreadsheets in a
workbook. An example of MSI and SCD sections is
given in Figures 1 and 2, respectively.
The MSI section of a SampleTab ﬁle has row-based
formatting where the ﬁrst column consists of attributes
describing four categories of information. These are: the
BioSD submission, any associated publications, organiza-
tions and contacts. At a minimum, the following must
be included: Submission Title, Submission SampleTab
Version and either an organization or individual email
address for contact.
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attribute names. Each subsequent row represents a sample
(or several samples derived from each other). Not every
sample has to have a value for each attribute, for example,
where no data are available (e.g. Sex of AsSMC and
Astrocy samples in Figure 2). As a minimum, each
sample must have a ‘Sample Name’. It is expected that
almost all submitted samples will contain an ‘Organism’
attribute specifying the species, though for some data
this may not be applicable (e.g. meta-genomic samples).
Most samples will also contain a ‘MaterialType’ attri-
bute—e.g. puriﬁed DNA, cell line, blood sample. We en-
courage the submitters to provide additional information,
such as collection location, genetic modiﬁcations. It is also
possible to encode relationships between the samples, such
as derived from relationship between individuals and
blood samples taken from them.
We do not seek to specify what information must be
provided in SampleTab ﬁles based on a priori assumptions
of the data; the format and the process of submission
Figure 1. Example of the MSI section of a SampleTab ﬁle.
Figure 2. Example of the SCD section of a SampleTab ﬁle.
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change in the future as standards are developed and
applied. Therefore, submissions in SampleTab format
may provide any number of additional columns
labelled as either characteristics of the sample or
comments about the sample. This can be seen in
Figure 2 in the ‘Characteristic[Karyotype]’ column and
‘Comment[Lineage]’columns. Through this mechanism,
submitters can capture information relevant to them in
terminology they are familiar with, without being
required to understand lengthy and technical speciﬁcation
documents.
Submission to BioSD is via email to biosamples@
ebi.ac.uk using submission templates. Additional submis-
sion tools and routes are in development and will be
released as open source applications. Pre-submission
enquiries and data retrieval queries can also be directed
to that address. Managed format extensions and subse-
quent versions of SampleTab will be available to
support the future needs of submitters and for data
exchange. We welcome comments and feedback on the
SampleTab format.
BioSD QUERY INTERFACE, APIs AND CONTENT
BioSD contents can be browsed or queried by sample or
sample group attributes, such as ‘blood’, ‘human’,
‘cancer’, ‘ENCODE’. The user interface follows the
group/sample concept and represents search results as a
list of groups that match the query criteria. For querying a
common search engine-like syntax is used; users can enter
a combination of keywords of interest. Logical expres-
sions with operations like AND, NOT are also supported.
Search results can be restricted by hits in groups, samples,
attributes names, attribute values and any combination of
the above, and by source: assay databases, or reference
layer samples.
Every group record in the search result list can be
expanded to provide more detailed information including:
contacts, publications, afﬁliations. In addition to the
group description, the list of samples in the group is
shown (see Figure 3). Each row corresponds to one
sample, and each column denotes one sample attribute.
Users can choose to view the complete sample group, or
the subset of samples matching the input query.
By the end of 2011, the BioSD will contain over 1
million samples from reference collections and EBI assay
databases including ArrayExpress [including GEO
database exchanged data (12)] and the SRA component
of the European Nucleotide Archive (2). An automated
pipeline system was constructed to extract, parse and load
data from each source via existing database APIs, or from
ﬁle downloads where no suitable API was available. For
example, International Mouse Strain Repository (IMSR)
Figure 3. Example of search results in BioSD web interface.
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through http://www.ﬁndmice.org/reportlist.jsp. For each
of these diverse sources, custom format conversion
software was developed to generated SampleTab format.
Further processing steps assign accessions to samples and
to groups, combine samples into submissions, ensure
controlled vocabulary and literature references are valid.
FUTURE
BioSD already contains information about substantial
number of reference samples that are routinely used in
functional genomics experiments. We encourage the scien-
tiﬁc community to reference these samples by their acces-
sion numbers, in particular, when data obtained by
assaying them are submitted to any of the EBI assay data-
bases. If necessary or desired, additional information
about the samples can be added. We will work with all
the EBI assay databases to make sure that accessing and
referencing existing samples in BioSD is simple. As some
assay databases also hold sample information locally, we
will establish a system that automatically pushes requested
sample information from BioSD into the respective assay
database. There will also be a mechanism for handling
coordinated multi-omics submissions across assay data-
bases at the EBI.
One of the tasks for BioSD is to establish submission
modiﬁcation tools that allow the submitters to add or edit
information about existing samples easily. Ensuring that
the sample information in BioSD is consistent and
updated is a non-trivial issue. Many of the sources used
do not expose an API with updates by type. Instead,
we periodically re-parse all the source information,
compare with information previously loaded into the
BioSample Database, and update where appropriate.
Improvement of existing APIs will make this process con-
siderably easier.
We will continue to work with the reference sample col-
lection owners to populate the BioSD with sample infor-
mation. Online submission tools will be developed to
make SampleTab submissions easier for direct submitters.
The reference layer will also be gradually expanded
through the curation of sample information present in
the EBI assay databases where these samples fulﬁl the
reference layer criteria developed jointly with the NCBI.
All the reference samples will be exchanged with the
BioSample Database at NCBI, and the information
about these will be held in both databases.
It is possible to navigate from samples and groups in
BioSD to relevant assays in assay databases to retrieve the
assay data by following the hyperlink. Some databases
(including ArrayExpress) currently do not accession indi-
vidual samples, which makes it non-straight forward to
create and maintain links to individual assays from
individual samples in BioSD. Sample links have been cur-
rently implemented for ENA and PRIDE with group links
for ENA and ArrayExpress. To make the BioSD database
more useful, in future hyperlinks from individual samples
in BioSD to assay data in all assay databases will be
provided.
A controlled access mechanism allowing the users to
keep their sample descriptions private either for later
release (e.g. after a publication), or to enable restricted
access compliant with ethical requirements is under test.
The GUI will be further developed to enable more
sophisticated queries, ﬁltering of existing search results,
improved layout and information download. Query
power will be improved by using the Experimental
Factor Ontology (EFO) (9) based query expansion; for
instance, a search for ‘cancer’ would match all the
subtypes and synonyms of cancer, such as ‘carcinoma’
and ‘malignant neoplasia’. In addition, as the user-base
of the BioSamples Database expands and diversiﬁes, we
will conduct user experience studies to determine other
areas for improvement.
Figure 4. Overview of future integration between BioSD and other EBI databases.
Nucleic Acids Research, 2012,Vol.40, Database issue D69In future, BioSD will become the central location where
all information about biological samples at the EBI
(see Figure 4) are stored and referenced from other
relevant databases within the EBI, as well as externally,
and where such information can be easily queried and
discovered.
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